McGranahan, Tresa
Therkelsen, Kate Elizabeth
Ahmad, Sarah
Nagpal, Seema
Article History
First Online: 21 February 2019
Compliance with Ethical Standards
:
: Tresa McGranahan declares that she has no conflict of interest. Kate Elizabeth Therkelsen declares that she has no conflict of interest. Sarah Ahmad declares that she has no conflict of interest. Seema Nagpal has received clinical trial funding from Inovio/Regeneron and Tocagen, has received research support from Nektar Therapeutics, and has received compensation from Nektar Therapeutics for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by any of the authors.